
Ginkgo Bioworks Holdings Inc (DNA) Stock: Analyzing the Market Value
The 36-month beta value for DNA is at 1.29. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0
The 36-month beta value for DNA is at 1.29. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0
Ginkgo Bioworks Holdings Inc (NYSE: DNA)’s stock price has dropped by -7.98 in relation to previous closing price of 8.02. Nevertheless, the company has seen
The stock of Ginkgo Bioworks Holdings Inc (DNA) has gone down by -7.88% for the week, with a -1.30% drop in the past month and
Additionally, the 36-month beta value for DNA is 1.00. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0
The stock of Ginkgo Bioworks Holdings Inc (DNA) has gone up by 12.46% for the week, with a -14.99% drop in the past month and
The stock of Ginkgo Bioworks Holdings Inc (DNA) has seen a -10.82% decrease in the past week, with a -26.97% drop in the past month,
The stock price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) has dropped by -6.60 compared to previous close of 7.12. Despite this, the company has
In the past week, DNA stock has gone up by 10.99%, with a monthly decline of -43.45% and a quarterly plunge of -23.97%. The volatility
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.